Homocystinuria: Clinical Trials

5 trials for Homocystinuria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 suspended, 1 terminated. 5 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 2, Recruiting 1, Suspended 1, Terminated 1
Phase 24Completed 1, Recruiting 1, Suspended 1, Terminated 1

Follow Homocystinuria: new trials by email Literature Review of Homocystinuria trials Research Report on Homocystinuria

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability and Pharmacodynamics of SYNB1353 in Healthy Adult Volunteers
SYNB1353 - Homocystinuria
Phase 1CompletedSynlogic312022-07-072023-03-17
Effect of Acetaminophen and N-Acetylcysteine on Liver Metabolism on Homocystinuria
Acetaminophen, N-acetylcysteine - CBS Deficiency
Phase 1 / Phase 2SuspendedHospital de Clinicas de Porto Alegre102022-02-112021-06-30
A Multiple Ascending Dose Study of ACN00177 (Pegtarviliase) in Subjects With CBS Deficiency
Pegtarviliase IV, Pegtarviliase SC - Homocystinuria Due to Cystathionine Beta-Synthase Deficiency
Phase 1 / Phase 2TerminatedAeglea Biotherapeutics132021-05-132023-07-27
Pegtibatinase as a Treatment for Patients With Classical Homocystinuria (HCU) (Also Known as the COMPOSE Study)
Pegtibatinase, Placebo - Homocystinuria
Phase 1 / Phase 2RecruitingTravere Therapeutics, Inc.392019-01-222026-08-10
Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine
taurine - Homocystinuria
Phase 1 / Phase 2CompletedUniversity of Colorado, Denver152010-01-012018-07-09

Narrower conditions

Metabolism, Inborn Errors (1)

Broader conditions

Amino Acid Metabolism, Inborn Errors (5)  ·  Brain Diseases (5)  ·  Brain Diseases, Metabolic (5)  ·  Brain Diseases, Metabolic, Inborn (5)  ·  Central Nervous System Diseases (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Connective Tissue Diseases (5)  ·  Genetic Diseases, Inborn (5)  ·  Hyperhomocysteinemia (5)  ·  Metabolic Diseases (5)  ·  Nervous System Diseases (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Metabolism, Inborn Errors (4)

Interventions

Acetaminophen (1)  ·  Acetylcysteine (1)  ·  Taurine (1)

Sponsors

Aeglea Biotherapeutics (1)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  Synlogic (1)  ·  Travere Therapeutics, Inc. (1)  ·  University of Colorado, Denver (1)

Countries

United States (4)  ·  Australia (1)  ·  Brazil (1)  ·  France (1)  ·  Qatar (1)  ·  United Kingdom (1)

Top investigators

Cortney Caudill (1)  ·  Ida VD Schwartz, PhD (1)  ·  Johan VanHove, MD PhD MBA (1)  ·  Michael Imperiale, MD (1)

Results publications

PMID 40382700

NIH funding

2019 (1)